1. Kovacevic, B. and Z.B. Maksic, Basicity of some organic superbases in acetonitrile. Organic Letters, 2001. 3(10): p. 1523-1526.
2. Komatsu, K. and T. Kitagawa, Cyclopropenylium cations, cyclopropenones, and heteroanalogues recent advances. Chemical reviews, 2003. 103(4): p. 1371-1428.
3. Bruns, H., et al., Synthesis and Coordination Properties of Nitrogen (I)‐Based Ligands. Angewandte Chemie International Edition, 2010. 49(21): p. 3680-3683.
4. Bandar, J.S. and T.H. Lambert, Enantioselective brønsted base catalysis with chiral cyclopropenimines. Journal of the American Chemical Society, 2012. 134(12): p. 5552-5555.
5. Maksic, Z.B. and B. Kovacevic, Spatial and electronic structure of highly basic organic molecules: Cyclopropeneimines and some related systems. The Journal of Physical Chemistry A, 1999. 103(33): p. 6678-6684.
6. Bandar, J.S. and T.H. Lambert, Cyclopropenimine-catalyzed enantioselective mannich reactions of tert-butyl glycinates with n-boc-imines. Journal of the American Chemical Society, 2013. 135(32): p. 11799-11802.
7. Bandar, J.S., et al., Structure–activity relationship studies of cyclopropenimines as enantioselective Bronsted base catalysts. Chemical science, 2015. 6(2): p. 1537-1547.
8. Neri, P., J.L. Sessler, and M.-X. Wang, Calixarenes and beyond. 2016: Springer.
9. Mutihac, L., et al., Recognition of amino acids by functionalized calixarenes. Chemical Society Reviews, 2011. 40(5): p. 2777-2796.
10. Zadmard, R. and T. Schrader, DNA recognition with large calixarene dimers. Angewandte Chemie International Edition, 2006. 45(17): p. 2703-2706.
11. Ozyilmaz, E., M. Bayrakci, and M. Yilmaz, Improvement of catalytic activity of Candida rugosa lipase in the presence of calix [4] arene bearing iminodicarboxylic/phosphonic acid complexes modified iron oxide nanoparticles. Bioorganic chemistry, 2016. 65: p. 1-8.
12. Yousaf, A., et al., Applications of calixarenes in cancer chemotherapy: facts and perspectives. Drug design, development and therapy, 2015. 9: p. 2831.
13. Karakurt, S., et al., Calixarenes in lipase biocatalysis and cancer therapy. Current Organic Chemistry, 2016. 20(10): p. 1043-1057.
14. Oguz, M., et al., Synthesis of New Picolylamine Bearing Calix [8] arene Derivatives as Antiproliferative Agents for Colorectal Carcinoma. ChemistrySelect, 2020. 5(39): p. 12250-12254.
15. Oguz, M., et al., Synthesis of calix [4] azacrown substituted sulphonamides with antioxidant, acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic anhydrase inhibitory action. Journal of enzyme inhibition and medicinal chemistry, 2020. 35(1): p. 1215-1223.
16. Oguz, M., et al., Formation of the inclusion complex of water soluble fluorescent calix [4] arene and naringenin: solubility, cytotoxic effect and molecular modeling studies. Journal of Biomolecular Structure and Dynamics, 2020. 38(13): p. 3801-3813.
17. An, L., et al., Design, synthesis and evaluation of calix [4] arene-based carbonyl amide derivatives with antitumor activities. European Journal of Medicinal Chemistry, 2021. 210: p. 112984.
18. An, L., et al., Synthesis, X-ray crystal structure and anti-tumor activity of calix [n] arene polyhydroxyamine derivatives. European journal of medicinal chemistry, 2016. 123: p. 21-30.
19. Williams, G.T., et al., Advances in applied supramolecular technologies. Chemical Society Reviews, 2021.
20. Rocha-Brito, K.J.P., et al., Calix [6] arene diminishes receptor tyrosine kinase lifespan in pancreatic cancer cells and inhibits their migration and invasion efficiency. Bioorganic chemistry, 2020. 100: p. 103881.
21. Yilmaz, B., A.T. Bayrac, and M. Bayrakci, Evaluation of anticancer activities of novel facile synthesized calix [n] arene sulfonamide analogs. Applied biochemistry and biotechnology, 2020. 190(4): p. 1484-1497.
22. Pur, F.N., Calix [4] API-s: fully functionalized calix [4] arene-based facial active pharmaceutical ingredients. Molecular diversity, 2020: p. 1-12.
23. Goh, C.Y., et al., The inhibitory properties of acidic functionalised calix [4] arenes on human papillomavirus pentamer formation. Supramolecular Chemistry, 2020. 32(5): p. 345-353.
24. Lappchen, T., et al., Novel analogs of antitumor agent calixarene 0118: Synthesis, cytotoxicity, click labeling with 2-[18F] fluoroethylazide, and in vivo evaluation. European Journal of Medicinal Chemistry, 2015. 89: p. 279-295.
25. Dings, R.P., et al., Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer. Investigational new drugs, 2013. 31(5): p. 1142-1150.
26. Hoskins, C. and A.D. Curtis, Simple calix [n] arenes and calix [4] resorcinarenes as drug solubilizing agents. Journal of Nanomedicine Research, 2015. 2(3).
27. Wang, G.-S., et al., Preparation and characterization of inclusion complexes of topotecan with sulfonatocalixarene. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 2011. 69(1-2): p. 85-89.
28. Yilmaz, M., et al., Inclusion of quercetin in gold nanoparticles decorated with supramolecular hosts amplifies its tumor targeting properties. ACS Applied Bio Materials, 2019. 2(7): p. 2715-2725.
29. Noruzi, E.B., et al., Para-sulfonatocalix [n] arene-based biomaterials: Recent progress in pharmaceutical and biological applications. European journal of medicinal chemistry, 2020. 190: p. 112121.
30. Coleman, W.A., et al., Calixarene derivatives as anticancer agent. 2010, US20100056482A1.
31. Fu, D., et al., Enantioselective Inhibition of human papillomavirus L1 pentamer formation by chiral-proline modified Calix [4] arenes: targeting the protein interface. Chemistry Select, 2016. 1: p. 6243-6243.
32. Oguz, M., et al., Synthesis and evaluation of the antitumor activity of Calix [4] arene L-proline derivatives. Bioorganic Chemistry, 2020. 94: p. 103207.
33. Chakrabarti, S., et al., Current protein-based anti-angiogenic therapeutics. Mini reviews in medicinal chemistry, 2014. 14(3): p. 291-312.
34. Dings, R.P., et al., Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding. Journal of medicinal chemistry, 2012. 55(11): p. 5121-5129.
35. Gutsche, C.D. and M. Iqbal, p‐tert‐Butylcalix [4] arene. Organic Syntheses, 2003. 68: p. 234-234.
36. Collins, E.M., et al., Chemically modified calix [4] arenes. Regioselective synthesis of 1, 3-(distal) derivatives and related compounds. X-Ray crystal structure of a diphenol-dinitrile. Journal of the Chemical Society, Perkin Transactions 1, 1991(12): p. 3137-3142.
37. Arnaud-Neu, F., et al., Synthesis, X-ray crystal structures, and cation-binding properties of alkyl calixaryl esters and ketones, a new family of macrocyclic molecular receptors. Journal of the American Chemical Society, 1989. 111(23): p. 8681-8691.
38. Karakurt, S., G. Abusoglu, and Z.C. Arituluk, Comparison of anticarcinogenic properties of Viburnum opulus and its active compound p-coumaric acid on human colorectal carcinoma. Turk J Biol, 2020. 44(5): p. 252-263.